butyric acid has been researched along with teleocidin b-4 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, Y; Kurokawa, K; Tsukamoto, A | 1 |
| Dokhélar, MC; Garson, D; Mishal, Z; Tursz, T; Wakasugi, H | 1 |
| Balana, A; Mishal, Z; Tetaud, C; Tursz, T; Wiels, J | 1 |
3 other study(ies) available for butyric acid and teleocidin b-4
| Article | Year |
|---|---|
Novobiocin modulates cytokeratin assembly and differentiation of human hepatoma cells induced by butyrate and teleocidin.
Topics: Acetylation; Butyrates; Butyric Acid; Carcinogens; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Drug Synergism; Humans; Keratins; Liver Neoplasms; Lyngbya Toxins; Novobiocin; Peptide Fragments; Procollagen; Tumor Cells, Cultured | 1991 |
HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon.
Topics: Burkitt Lymphoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Gene Expression Regulation; HLA Antigens; Humans; Hybrid Cells; Interferon Type I; Interferon-gamma; Leukemia; Lyngbya Toxins; Phenotype; Tetradecanoylphorbol Acetate | 1985 |
Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiation.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; B-Lymphocytes; Burkitt Lymphoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Cell Line; Cytophotometry; Flow Cytometry; Glycolipids; Humans; Lyngbya Toxins; Tetradecanoylphorbol Acetate | 1985 |